Critical care for dengue in adult patients: An overview of current knowledge and future challenges

Current Opinion in Critical Care

Volumn 22, Issue 5, 2016, Pages 485-490

  Pang, Junxiong ^a,b   Leo, Yee Sin ^a,b,c,d   Lye, David C ^a,c,d  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

dengue; intensive care; mortality; multiorgan dysfunction; risk factors

Indexed keywords

ADULT DISEASE; BACTEREMIA; CLINICAL FEATURE; COMORBIDITY; DENGUE; EVIDENCE BASED PRACTICE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INFECTION RISK; INTENSIVE CARE; INTENSIVE CARE UNIT; MORTALITY RISK; OUTCOME ASSESSMENT; REVIEW; RISK FACTOR; SEVERE DENGUE; ADULT; MORTALITY;

ADULT; CRITICAL CARE; DENGUE; HUMANS; INTENSIVE CARE UNITS; RISK FACTORS;

EID: 84987781404     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000339     Document Type: Review

References (57)

1. Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: A systematic analysis. Lancet Infect Dis 2016. [Epub ahead of print]
2. Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: An analysis from the Global Burden of Disease Study. Lancet Infect Dis 2016; 16:712-723.
3. Simmons CP, Farrar JJ, Nguyen vV, Wills B. Dengue. N Engl J Med 2012; 366:1423-1432.
4. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013; 496:504-507.
5. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005; 353:877-889.
6. Lam PK, Tam DT, Diet TV, et al. Clinical characteristics of dengue shock syndrome in Vietnamese children: A 10-year prospective study in a single hospital. Clin Infect Dis 2013; 57:1577-1586.
7. Goonasekera CD, Thenuwara BG, Kumarasiri RP. Peritoneal dialysis in dengue shock syndrome may be detrimental. J Trop Med 2012; 2012:917947.
8. Pang J, Thein TL, Leo YS, Lye DC. Early clinical and laboratory risk factors of intensive care unit requirement during 2004-2008 dengue epidemics in Singapore: A matched case-control study. BMC Infect Dis 2014; 14:649.
9. Schmitz L, Prayag S, Varghese S, et al. Nonhematological organ dysfunction and positive fluid balance are important determinants of outcome in adults with severe dengue infection: A multicenter study from India. J Crit Care 2011; 26:441-448.
10. Juneja D, Nasa P, Singh O, et al. Clinical profile, intensive care unit course, and outcome of patients admitted in intensive care unit with dengue. J Crit Care 2011; 26:449-452.
11. Chandralekha, Gupta P, Trikha A. The north Indian dengue outbreak 2006: A retrospective analysis of intensive care unit admissions in a tertiary care hospital. Trans R Soc Trop Med Hyg 2008; 102:143-147.
12. Jog S, Prayag S, Rajhans P, et al. Dengue infection with multiorgan dysfunction: SOFA score, arterial lactate and serum albumin levels are predictors of outcome. Intensive Care Med 2015; 41:2029-2030.
13. Amancio FF, Heringer TP, de Oliveira Cda C, et al. Clinical profiles and factors associated with death in adults with dengue admitted to intensive care units, Minas Gerais, Brazil. PLoS One 2015; 10:e0129046.
14. Chen CM, Chan KS, Chao HC, Lai CC. Diagnostic performance of procalcitonin for bacteremia in patients with severe dengue infection in the intensive care unit. J Infect 2016. [Epub ahead of print]
15. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Intensive Care Med 2013; 39:165-228.
16. Zhang L, Chen Z, Diao Y, et al. Associations of fluid overload with mortality and kidney recovery in patients with acute kidney injury: A systematic review and meta-analysis. J Crit Care 2015; 30:860.e7-860.e13.
17. Yacoub S, Wills B. Predicting outcome fromdengue. BMCMed 2014; 12:147.
18. Yacoub S, Griffiths A, Chau TT, et al. Cardiac function in Vietnamese patients with different dengue severity grades. Crit Care Med 2012; 40:477-483.
19. Yacoub S, Wertheim H, Simmons CP, et al. Cardiovascular manifestations of the emerging dengue pandemic. Nat Rev Cardiol 2014; 11:335-345.
20. Somasetia DH, Setiati TE, Sjahrodji AM, et al. Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: A randomized single-blind clinical trial of efficacy and safety. Crit Care 2014; 18:466.
21. Medeiros DN, Ferranti JF, Delgado AF, de Carvalho WB. Colloids for the initial management of severe sepsis and septic shock in pediatric patients: A systematic review. Pediatr Emerg Care 2015; 31:e11-e16.
22. Nalos M, Tang BM, Nanan R. Is lactate the new panacea for endothelial dysfunction? Crit Care 2014; 18:614.
23. Khan Assir MZ, Kamran U, Ahmad HI, et al. Effectiveness of platelet transfusion in dengue fever: A randomized controlled trial. Transfus Med Hemother 2013; 40:362-368.
24. Lee TH, Wong JG, Leo YS, et al. Potential harm of prophylactic platelet transfusion in adult dengue patients. PLoS Negl Trop Dis 2016; 10:e0004576.
25. Thomas L, Kaidomar S, Kerob-Bauchet B, et al. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients. Transfusion 2009; 49:1400-1411.
26. Zhang F, Kramer CV. Corticosteroids for dengue infection. Cochrane Database Syst Rev 2014; 7:CD003488.
27. Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC. Corticosteroids in the treatment of dengue shock syndrome. Infect Drug Resist 2014; 7:137-143.
28. Wali JP, Biswas A, Handa R, et al. Dengue haemorrhagic fever in adults: A prospective study of 110 cases. Trop Doct 1999; 29:27-30.
29. Almas A, Parkash O, Akhter J. Clinical factors associated with mortality in dengue infection at a tertiary care center. Southeast Asian J Trop Med Public Health 2010; 41:333-340.
30. Ferreira FL, Bota DP, Bross A, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-1758.
31. Ong A, Sandar M, Chen MI, Sin LY. Fatal dengue hemorrhagic fever in adults during a dengue epidemic in Singapore. Int J Infect Dis 2007; 11:263-267.
32. Leo YS, Thein TL, Fisher DA, et al. Confirmed adult dengue deaths in Singapore: 5-year multicenter retrospective study. BMC Infect Dis 2011; 11:123.
33. Wang CC, Liu SF, Liao SC, et al. Acute respiratory failure in adult patients with dengue virus infection. Am J Trop Med Hyg 2007; 77:151-158.
34. Dubois MJ, Orellana-Jimenez C, Melot C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med 2006; 34:2536-2540.
35. Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 2012; 72:1491-1501.
36. Grander W, Dunser M, Stollenwerk B, et al. C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest 2010; 138:856-862.
37. Ranzani OT, Zampieri FG, Forte DN, et al. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One 2013; 8:e59321.
38. Grander W, Mullauer K, Koller B, et al. Heart rate before ICU discharge: A simple and readily available predictor of short- and long-term mortality from critical illness. Clin Res Cardiol 2013; 102:599-606.
39. Matsumura Y, Nakada TA, Abe R, et al. Serum procalcitonin level and SOFA score at discharge from the intensive care unit predict postintensive care unit mortality: A prospective study. PLoS One 2014; 9:e114007.
40. Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study. Lancet 2015; 386:743-800.
41. Rimes-Stigare C, Frumento P, Bottai M, et al. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Crit Care 2015; 19:383.
42. Kuo MC, Lu PL, Chang JM, et al. Impact of renal failure on the outcome of dengue viral infection. Clin J Am Soc Nephrol 2008; 3:1350-1356.
43. Htun NS, Odermatt P, Eze IC, et al. Is diabetes a risk factor for a severe clinical presentation of dengue? - review and meta-analysis. PLoS Negl Trop Dis 2015; 9:e0003741.
44. Thein TL, Leo YS, Fisher DA, et al. Risk factors for fatality among confirmed adult dengue inpatients in Singapore: A matched case-control study. PLoS One 2013; 8:e81060.
45. Bravo JR, Guzman MG, Kouri GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987; 81:816-820.
46. Cunha RV, Schatzmayr HG, Miagostovich MP, et al. Dengue epidemic in the State of Rio Grande do Norte, Brazil, in 1997. Trans R Soc Trop Med Hyg 1999; 93:247-249.
47. Gonzalez D, Castro OE, Kouri G, et al. Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, dengue 3 epidemic, 2001-2002. Int J Infect Dis 2005; 9:280-285.
48. See KC, Phua J, Yip HS, et al. Identification of concurrent bacterial infection in adult patients with dengue. Am J Trop Med Hyg 2013; 89:804-810.
49. Lee IK, Liu JW, Yang KD. Clinical characteristics and risk factors for concurrent bacteremia in adults with dengue hemorrhagic fever. Am J Trop Med Hyg 2005; 72:221-226.
50. Leelarasamee A, Chupaprawan C, Chenchittikul M, Udompanthurat S. Etiologies of acute undifferentiated febrile illness in Thailand. J Med Assoc Thai 2004; 87:464-472.
51. Laoprasopwattana K, Pruekprasert P, Dissaneewate P, et al. Outcome of dengue hemorrhagic fever-caused acute kidney injury in Thai children. J Pediatr 2010; 157:303-309.
52. Lee IK, Liu JW, Yang KD. Fatal dengue hemorrhagic fever in adults: Emphasizing the evolutionary prefatal clinical and laboratory manifestations. PLoS Negl Trop Dis 2012; 6:e1532.
53. Thein TL, Ng EL, Yeang MS, et al. Risk factors for concurrent bacteremia in adult patients with dengue. J Microbiol Immunol Infect 2015. [Epub ahead of print]
54. Lahiri M, Fisher D, Tambyah PA. Dengue mortality: Reassessing the risks in transition countries. Trans R Soc Trop Med Hyg 2008; 102:1011-1016.
55. Dellinger RP. The Surviving Sepsis Campaign: 2013 and beyond. Chin Med J (Engl) 2013; 126:1803-1805.
56. World Health Organization. Dengue: Guidelines for diagnosis, treatment, prevention, and control. New ed. Geneva: TDR/World Health Organization; 2009.
57. Brechot N, Hekimian G, Chastre J, Luyt CE. Procalcitonin to guide antibiotic therapy in the ICU. Int J Antimicrob Agents 2015; 46 (Suppl 1):S19-S24.